Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF | NRIFD

Nuvo Research, Inc. is a Canadian specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units: the Topical Products and Technology (TPT) Group (formerly the Pain Group) and the Immunology Group.
Price: $6.73 | Change: +$0.04 | %Change: +0.60%
Volume: 2,905 | Day High/Low: 6.97/6.64 | 52 Week High/Low: 8.33/1.93
View modes: 
5 stars

RE:Goodman says he is ready to make his move

If you ever watch Mad Money, one of his major points that comes up all the time when discussing companies management .  This Goodman doesnt sound like a knight..... he sounds more like more
1 star

RE:RE:Is Anon controling the pharma ETF's?

  rate and reply
1 star

RE:Is Anon controling the pharma ETF's?

  rate and reply
5 stars

Is Anon controling the pharma ETF's?

  rate and reply
5 stars

Anon Daily Trades ( Dec )..the essence of containment

Broker Positions for C:NRI Broker #1 from 20141201 to 20141226   Bought $Val Ave Sold $Val Ave Net Position more
5 stars

Goodman says he is ready to make his move

With the sale of Paladin Labs Inc. to the highest bidder in his rear view mirror,Jonathan Goodman believes he can strike gold again with his new company Knight Therapeutics   For Montré more
5 stars

RE:long history

And, of course, management have already alluded to their intent to monetize all assets, in the absence if their professed inexperience in drug sales and distribution. Including GUD equity as part more
5 stars

long history

This article dated back to 2008.  Thats a long relationship between Goodman and Nuvo.  Buyouts are always fun to speculate and there may not be one here.  Knight is looking to spend money and more
4 stars

RE:RE:RE:RE:RE:old news . Possibly why knight and nri will be one soon

July 8, 2008 7:00 AM - Financial - Medical/ Pharmaceuticals SAVE Nuvo Research and Paladin announce amendments to Pennsaid and Pennsaid Plus agreements more
0 stars

RE:RE:RE:RE:old news . Possibly why knight and nri will be one soon

So what would that amount to as a price per share? Sat you are not interested in GUD?  rate and reply
3 stars

RE:RE:RE:old news . Possibly why knight and nri will be one soon

If it was Knight (GUD) who solicited an offer to Nuvo, my guess would be to return the full amount of cash within the company to nuvo shareholders, plus pay out the exiting price per share(7 dollars) more
5 stars

RE:RE:old news . Possibly why knight and nri will be one soon

If either one of these two buy out Nuvo ,what are the chances that we would also get shares in their stock as part of the package ?  rate and reply
3.5 stars

RE:old news . Possibly why knight and nri will be one soon

The only uncertain element in the buyout of Nuvo by Knight is the price.....or Endo. Give back the $60 million in cash to shareholders and $20 per share for the equity. Nothing less will more
3 stars

RE:RE:RE:RE:RE:RE:Generic Pennsaid

I fail to understand why you are posting this irrelevant and out if date information . it has no real implication for Nuvo.  rate and reply
3 stars

old news . Possibly why knight and nri will be one soon

Nuvo Research(R) and Paladin Labs Announce Amendment to May 2012 Loan Arrangement T.NRI, T.PLB | June 17, 2013 Nuvo Research(R) and Paladin Labs Announce Amendment to more
5 stars

RE:RE:RE:RE:RE:Generic Pennsaid

That's old news. Pfizer won its court case and the patent was even extended to 2020... Viagra to go generic in 2017 according to Pfizer agreement FILE - In this Friday, March 2, 2012, more
3 stars

RE:RE:RE:RE:Generic Pennsaid

This is what happened to Viagra in Canada before the patent ran out .   Supreme Court backs Canadian firm’s bid to make generic Viagra Kirk Makin The Globe and more
5 stars

RE:RE:RE:Generic Pennsaid

Nuvo has already monetized this drug asset in the US. That is, other than a modest profit on manufacturing of P 2. As the patent has not expired, this is a pure fishing expedition by Watson.  rate and reply
3 stars

RE:RE:Generic Pennsaid

This company ( Watson Lab ) also from Ireland is already producing a generic Pennsaid 1.5  If you read the article they have now applied to the FDA for approval to make a generic version of Pennsaid more
3.5 stars

RE:RE:RE:DCF on a highly rsiked basis

Knight will be looking for the same asset type as Paladin. That is, current value plus future growth potential plus a large forward tax loss pools. Nuvo has over $100 million in tax loss pools , more

Featured News Links